Form 8-K · Current report
Corteva 8-K, filed Aug 6, 2026
- Filed
- CIK
- 0001755672
- Accession no.
- 0001193125-26-338406
Summary
Vylor Inc., a wholly owned Corteva subsidiary, has commenced private offers to exchange any and all outstanding EIDP, Inc. notes for new notes of corresponding series issued by Vylor, together with related consent solicitations to amend the indentures governing those notes, in connection with Corteva's planned separation into two independent publicly traded companies — one holding the crop protection business and one, Vylor, holding the seed business. The separation is expected to be consummated on or about October 1, 2026, subject to conditions including consummation of the separation itself and receipt of requisite consents by 5:00 p.m. New York City time on August 19, 2026.
Key points
- Corteva's board is pursuing a plan, announced October 1, 2025, to separate into two publicly traded companies: its crop protection business and its seed business, the latter to be owned by Vylor Inc.
- The exchange offers cover the 2.300% Senior Notes due 2030, 5.125% Senior Notes due 2032 and 4.800% Senior Notes due 2033 issued by EIDP, Inc.
- Each exchange offer and consent solicitation is conditioned on consummation of the separation, a condition that cannot be waived, and on receipt of Requisite Consents by August 19, 2026, unless extended or earlier terminated.
- The proposed base indenture amendments would eliminate substantially all restrictive covenants and events of default other than payment- and bankruptcy-related ones; supplemental indenture amendments would eliminate change-of-control repurchase provisions.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 Regulation FD Disclosure. In connection with the Exchange Offers and Consent Solicitations described below, Corteva, Inc. (the “Company” or “Corteva”) issued an exchange offer memorandum and consent solicitation statement, dated August 6, 2026 (the “Offering Memorandum”). Certain excerpts from the Offering Memorandum are attached as Exhibit 99.1 hereto and are incorporated by reference herein. The information contained in Exhibit 99.1 is excerpted from the Offering Memorandum that is being made available to the Eligible Holders (as defined below) in connection with the Exchange Offers and Consent Solicitations and includes (i) certain information not previously disclosed by the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.